med-tech recap preview
kick new decad disrupt
announc annual sf scrambl
suppli devic outlook new decad disrupt begin
bullish ms expect sustain organ growth drive
upsid outperform-r stock top pick ew
see digit health key theme identifi
privat med tech compani focus digit health outlook piec also includ
company-rel question company-rel catalyst
medic meet industri event pleas also see video
ortho confer bring togeth thought leader digit health orthopaed help
solv challeng clinician health system industri encount potenti
implic snn
forecast week call scatter flurri pre-announc
commentari usual see flurri pre-announc earli jan got
earli start gmed preliminari result name pre-
announc prior year includ occasion would also expect
also hear fair amount preliminari increment thought high-level color
ew two-stag valuat model boost confid price updat
two-stag valuat model ew support upsid next month
boost confid target price reiter outperform
sale in-lin estim street view sale guidanc
prudent way start year sop analysi suggest target multipl
reason potenti conserv reiter outperform price target
ms index ytd bp bp ms
ltm vs ms led group week
ytd lc growth diversifi ms ntm
ev/ebitda respect vs
figur weekli perform suppli devic ms
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
figur upcom event catalyst
ticker potenti implic
read-through devic trend cardio
ortho spine
read-through cardio ew diabet
cover
read-through ortho spine
read-through cardio
read-through ortho spine
fda public meet test method asbesto talc
cosmet product contain talc
advanc technolog treatment diabet attd
read-through cardio ew
read-through spine
feb evolv role artifici intellig radiolog imag
intern societi advanc spine surgeri san
addit name confirm
rais organ growth improv expect management
target higher growth vs see benefit healthi array
new product catalyst reiter outperform rais target
rais track exceed outlook
remain track meet exceed organ growth guidanc driven improv
execut robust pipelin drive continu growth
rais product cycl puls drive share gain see
increas adopt pull-through drive growth management continu
control roll-out puls see potenti share gain
beyond reiter outperform rais target
holt weekli analysi rank attract holt market
impli expect rank attract coverag univers
holt analysi also suggest valuat remain attract healthcar
subsector put med-tech fairli price rang
med-tech recap preview
figur week read research medic suppli devic
new decad disrupt begin highlight outlook suppli devic
decemb updat analysi oct-nov pharma trend continu trail estim slightli reiter outperform
neurovascular management highlight anoth one under-valued asset larg under-penetr market grow dd annual
us pharma updat oct-nov trend trail estim slightli pharma line track reiter outperform
rais target price manag track exceed outlook reiter outperform
track higher organ growth rais target price
regain competit foot innov driver reiter outperform rais target price
solid finish driven implant growth partial off-set robot guid in-lin ex-non-cash item reiter outperform
ew outlook touch better expect potenti expans lt tavr market reiter outperform rais target price
confer call event detail
credit suiss healthcar outlook call replay expir midnight
med-tech recap preview
cfo brian yoor step januari announc
brian yoor execut vice presid financ cfo retir effect
februari replac robert funck jr effect
march recent mr funck serv abt senior vice
presid financ control sinc serv vice presid
control prior vice presid chief
ethic complianc offic vice presid
intern audit vice presid treasur
mr funck join abbott
receiv fda approv less invas surgic techniqu
heartmat januari announc fda approv new
altern surgic techniqu heartmat heart pump allow
advanc heart failur patient avoid open heart surgeri approv
base elev multi-cent voluntari observ registri
collect post-market data lat feasibl studi singl arm
prospect multicent studi result two studi found
bleed requir surgeri infect arrhythmia lower
group implant via less-invas surgic approach
underw open heart surgeri heart pump typic implant via open
heart surgeri approv altern surgic techniqu
heartmat heart pump implant via later thoracotomi
incis made patient rib access heart
sever advantag open heart surgeri includ less bleed
shorter recoveri time patient context heartmat receiv
fda approv patient advanc heart failur whose heart
unabl circul blood bodi wait
transplant known bridg transplant heartmat
approv destin therapi individu need
new heart elig transplant
accus compani play key role drive entir
pharmaceut industri expand use prescript opioid
lawsuit also assert fuel opioid epidem washington state
embark massiv decept market campaign convinc
doctor public drug effect treat chronic pain
low risk addict lawsuit file king counti
superior court context mr ferguson file lawsuit purdu
pharma march file suit three largest
distributor prescript opioid washington state mckesson corp
cardin health inc amerisourcebergen drug corp trial
schedul octob
acquir stimgen novel spinal cord stimul therapi
januari announc acquir privately-held stimgen
llc undisclos amount deal expect neutral
ep stimgen develop spinal cord stimul waveform known
differenti target multiplex dtm spinal cord stimul
modul neuron glial cell shown statist signific
revers pain behavior compar either low frequenc high
anim model addit pre-clin studi
med-tech recap preview
investig genom nerve-injur anim suggest
dtm waveform greater impact neural-gli interact
frequenc alon three-month result random control trial
evalu dtm vs convent present
receiv ce mark approv percept pc neurostimul
db system januari announc ce mark approv
percept pc neurostimul deep brain stimul db system
launch eu mdt brainsens technolog sens
record brain signal deliv therapi patient neurolog
disord percept also featur mr condit label full-
bodi mri scan improv batteri longev compar mdt activa pc
neurostimul expand stimul option percept current
appoint new cfo januari announc
appoint matthew harbaugh execut vice presid cfo
effect immedi succeed raj asarpota transit
compani recent mr harbaugh serv presid
specialti gener busi plc prior
cfo five year mr harbaugh previous held
varieti financi manag posit covidien pharmaceut
spun covidien plc plc juli join
covidien mr asarpota remain advisori role
may assist transit duti thereaft provid
on-going consult servic septemb compani also
re-affirmed annual financi guidanc full-year
/wmgi deal receiv second request januari
note feder trade commiss extend review
compani deal decemb compani receiv second
request ask inform examin competit effect
notic could delay deal close estim end
compani estim level ftc review remain bullish
deal expect significantli enhanc syk robot
surgeri program upper lower extrem
med-tech recap preview
figur last week med-tech bp bp bp hc
med-tech recap preview
figur last week ms in-lin disrupt ms bp
figur last month disrupt ms lead ms
med-tech recap preview
figur last month disrupt ms index outperform smid lc
disrupt ms index pro-rata weight perform alc ew base
proport revenu driven disrupt technolog
med-tech recap preview
figur ntm ev/ebitda coverag univers
med-tech recap preview
med-tech recap preview
holt market impli expect analysi indic valuat conserv
healthcar subsector holt use revers dcf quantifi market impli
expect calcul futur level return capit cfroi requir justifi
today valuat market impli expect green dot consensu
forecast pink bar indic attract valuat upsid potenti stock
figur healthcar holt cfroi ntm forecast return capit vs market-impli spread
note aggreg ex financi regul util reit data shown base constitu median
med-tech recap preview
return capit cfroi histor forecast market impli median industryspread forecast vs market impli return capitalconserv expect current price impli declin returnsdemand expect current price impli increas itlif scitot hcmedtechcfroi year mediancfroi lfycfroi consensu forecast ntm market impli itlif scitot hcmedtechposit spread currentneg spread year median charl martineau pm univers toronto januari
market impli expect coverag univers med-tech gener demand
rel sell side forecast holt market impli expect analysi reveal
attract consensu forecast cfroi market impli
expect demand expect
figur med-tech holt cfroi ntm forecast return capit vs market-impli spread
contact inform holt
med-tech recap preview
mediancfroi lfycfroi consensu forecast ntm market impli spread currentneg spread year median spreadreturn capit cfroi histor forecast market impliedspread forecast vs market impli return capit conserv expect current price impli declin returnsdemand expect current price impli increas charl martineau pm univers toronto
compani mention price
